Skip to main content

. 1963 Sep 28;2(5360):776–781. doi: 10.1136/bmj.2.5360.776

Guanethidine in the Treatment of Hypertension

Clifton P Lowther, Richard W D Turner

PMCID: PMC1872845 PMID: 14061324

776

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

EAGAN J. T., ORGAIN E. S. A study of 38 patients and their responses to guanethidine. A new antihypertensive agent. JAMA. 1961 Feb 18;175:550–553. doi: 10.1001/jama.1961.03040070008002. [DOI] [PubMed] [Google Scholar]
FIFE R., MORAN F., PRINEAS J. Treatment of hypertension in out-patients: mecamylamine, bretylium and guanethidine. Scott Med J. 1962 Dec;7:516–523. doi: 10.1177/003693306200701203. [DOI] [PubMed] [Google Scholar]
LEISHMAN A. W., MATTHEWS H. L., SMITH A. J. Further experience with guanethidine. Lancet. 1961 Jul 1;2(7192):4–7. doi: 10.1016/s0140-6736(61)92702-7. [DOI] [PubMed] [Google Scholar]
LOWTHER C. P., TURNER R. W. Sympathetic blockade in treatment of hypertension. Clinical trial of bretylium tosylate. Br Med J. 1960 Oct 8;2(5205):1049–1053. doi: 10.1136/bmj.2.5205.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
PAGE I. H., HURLEY R. E., DUSTAN H. P. The prolonged treatment of hypertension with guanethidine. JAMA. 1961 Feb 18;175:543–549. doi: 10.1001/jama.1961.03040070001001. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES